Healthcare
Rest Ez Inc.(RTEZ)
Live Price
Offline$70.00
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
- Market Cap
- $1.93B
- Revenue Growth
- -100.0%
- EPS Growth
- +70.1%
- Dividend Yield
- 0.0%
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rest Ez Inc. (RTEZ) is a Healthcare stock with a market cap of $1.93B and listed on OTC. The stock last traded around $70.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +70.1%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +70.1%, free cash flow +56.7% with operating margin 0.0% and ROIC 11.0%. Valuation already assumes a fairly strong business story at P/E 58411.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RTEZ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-100.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
P/E
Above sector median
58411.8 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -100.0% and EPS is at +70.1%, with operating margin around 0.0%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RTEZ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RTEZ Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RTEZ and SPY.
Company Overview
Rest Ez Inc.
Other OTC
Rest EZ, Inc. produces and distributes sleeping aid soft gel capsules in the United States. The company offers Rest EZ, a sleep aid supplement soft gel capsule. It provides its products through wholesalers and retailers, as well as online through www.RestEz.net. The company was incorporated in 2016 and is based in Riverton, Utah.
- Leadership
- Dylan Carson
- IPO Date
- Jun 2, 2025
- Employees
- 5
- Street Address
- 1398 West Mason Hollow Drive
- Mailing
- Riverton, UT, 84065
- Region
- Riverton, UT, US
- Reporting Currency
- USD
- Investor Line
- 801 300 2542
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 58411.8
- EV/EBITDA
- 58411879.1
- Price/Sales
- —
- Price/Book
- 6425.3
Growth
- Revenue
- -100.0%
- EPS
- +70.1%
- Free Cash Flow
- +56.7%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 11.0%
- ROIC
- 11.0%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- —
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.